The Path Forward From COVID-19
May 14, 2020
As states and local governments contemplate a return to communal life, many of us have lingering questions about Covid-19 testing, treatment and vaccination. Recently Glenmede’s CEO, Gordon Fowler, spoke with two specialists in the fields of immunology and immunotherapy.
Featuring guest speakers, Marion Pepper, Ph.D., Associate Professor in the Department of Immunology at the University of Washington School of Medicine and David B. Weiner, Ph.D., Director of the Vaccine and Immunotherapy Center, the W.W. Smith Charitable Trust Professor in Cancer Research and Executive Vice President of The Wistar Institute.